CCM Therapy: New Optimizer implant can improve quality of life for CHF patients
CAMC is proud to offer the first and only FDA-approved device in the United States for the delivery of cardiac contractility modulation (CCM) therapy – The Optimizer Implant.
Delivered by the Optimizer implant, CCM Therapy can:
CCM therapy may be an option for people who aren’t adequately responding to heart failure medications.1
The therapy has been proven to be safe and effective in numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.2
The therapy is covered by Medicare and is increasingly covered by commercial insurers.
Delivered by the Optimizer implant, CCM Therapy is a new treatment that:
Heart failure medications aren’t always enough to help people feel better
1 Abraham WT, Kuck KH, Goldsmith RL, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Failure. 6(10), 874-883 (2018).
2 Clinical evidence on file: https://impulse-dynamics.com/providers/clinical-trials/